Literature DB >> 17102593

The minimum element of a synthetic peptide required to block prostate tumor cell migration.

Thomas C Sroka1, Jan Marik, Michael E Pennington, Kit S Lam, Anne E Cress.   

Abstract

Human prostate tumor cell invasion and metastasis are dependent in part on cell adhesion to extracellular matrix proteins and cell migration. We previously identified a synthetic D-amino acid tumor cell adhesion peptide called HYD1 (kikmviswkg) that supported adhesion of tumor cells derived from breast, prostate, ovary and pancreas tissue. Alanine substitution analysis and a peptide deletion strategy were used to determine the minimal element of HYD1 necessary for bioactivity in a prostate cancer cell line called PC3N. Bioactivity was measured by assays of cell adhesion, migration and ERK signaling. The most potent element of HYD1 necessary to support cell adhesion was kmvixw, the block to migration required xkmviswxx and activation of ERK signaling required ikmviswxx. The shortest sequence active in all three assays was iswkg. The HYD1 peptide contains overlapping elements required for adhesion, blocking migration and the activation of ERK signaling. These linear peptide sequences provide the starting point for development of novel compounds to target cancer cell adhesion and migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102593      PMCID: PMC2704570          DOI: 10.4161/cbt.5.11.3461

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  53 in total

Review 1.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 2.  Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research.

Authors:  Kit S Lam; Ruiwu Liu; Suzanne Miyamoto; Alan L Lehman; Joseph M Tuscano
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

3.  Culture conditions affect expression of the alpha 6 beta 4 integrin associated with aggressive behavior in head and neck cancer.

Authors:  T E Carey; L Laurikainen; A Ptok; T Reinke; K Linder; T S Nair; C Marcelo
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

4.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

5.  Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia.

Authors:  H Nakahara; S C Mueller; M Nomizu; Y Yamada; Y Yeh; W T Chen
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

6.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Authors:  J C Gutheil; T N Campbell; P R Pierce; J D Watkins; W D Huse; D J Bodkin; D A Cheresh
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

7.  Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.

Authors:  Li Peng; Ruiwu Liu; Jan Marik; Xiaobing Wang; Yoshikazu Takada; Kit S Lam
Journal:  Nat Chem Biol       Date:  2006-06-11       Impact factor: 15.040

8.  Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth.

Authors:  M Lourdes Ponce; Suguru Hibino; Agata M Lebioda; Mayumi Mochizuki; Motoyoshi Nomizu; Hynda K Kleinman
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 9.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  Synthetic peptides from the carboxy-terminal globular domain of the A chain of laminin: their ability to promote cell adhesion and neurite outgrowth, and interact with heparin and the beta 1 integrin subunit.

Authors:  A P Skubitz; P C Letourneau; E Wayner; L T Furcht
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  5 in total

Review 1.  From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides.

Authors:  Aitor Blanco-Míguez; Alberto Gutiérrez-Jácome; Martín Pérez-Pérez; Gael Pérez-Rodríguez; Sandra Catalán-García; Florentino Fdez-Riverola; Anália Lourenço; Borja Sánchez
Journal:  Protein Sci       Date:  2016-04-19       Impact factor: 6.725

2.  Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.

Authors:  Lipsa Das; Todd A Anderson; Jaime M C Gard; Isis C Sroka; Stephanie R Strautman; Raymond B Nagle; Colm Morrissey; Beatrice S Knudsen; Anne E Cress
Journal:  J Cell Biochem       Date:  2017-01-05       Impact factor: 4.429

3.  Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β-hairpin-like scaffold, MTI-101.

Authors:  Priyesh Jain; David B Badger; Yi Liang; Anthony W Gebhard; Daniel Santiago; Philip Murray; Sridhar R Kaulagari; Ted J Gauthier; Rajesh Nair; MohanRaja Kumar; Wayne C Guida; Lori A Hazlehurst; Mark L McLaughlin
Journal:  Pept Sci (Hoboken)       Date:  2020-10-09

4.  Inhibitory Effects of PEI-RGD/125I-(αv) ASODN on Growth and Invasion of HepG2 Cells.

Authors:  Haidong Cai; Yu Qiao; Ming Sun; Xueyu Yuan; Qiong Luo; Yuehua Yang; Shidong Yuan; Zhongwei Lv
Journal:  Med Sci Monit       Date:  2015-08-10

5.  Tumour exosome integrins determine organotropic metastasis.

Authors:  Ayuko Hoshino; Bruno Costa-Silva; Tang-Long Shen; Goncalo Rodrigues; Ayako Hashimoto; Milica Tesic Mark; Henrik Molina; Shinji Kohsaka; Angela Di Giannatale; Sophia Ceder; Swarnima Singh; Caitlin Williams; Nadine Soplop; Kunihiro Uryu; Lindsay Pharmer; Tari King; Linda Bojmar; Alexander E Davies; Yonathan Ararso; Tuo Zhang; Haiying Zhang; Jonathan Hernandez; Joshua M Weiss; Vanessa D Dumont-Cole; Kimberly Kramer; Leonard H Wexler; Aru Narendran; Gary K Schwartz; John H Healey; Per Sandstrom; Knut Jørgen Labori; Elin H Kure; Paul M Grandgenett; Michael A Hollingsworth; Maria de Sousa; Sukhwinder Kaur; Maneesh Jain; Kavita Mallya; Surinder K Batra; William R Jarnagin; Mary S Brady; Oystein Fodstad; Volkmar Muller; Klaus Pantel; Andy J Minn; Mina J Bissell; Benjamin A Garcia; Yibin Kang; Vinagolu K Rajasekhar; Cyrus M Ghajar; Irina Matei; Hector Peinado; Jacqueline Bromberg; David Lyden
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.